拱东医疗
(605369)
| 流通市值：40.97亿 | | | 总市值：40.97亿 |
| 流通股本：2.20亿 | | | 总股本：2.20亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 288,585,340.3 | 1,135,701,442.27 | 845,084,320.3 | 556,922,772 |
| 营业收入 | 288,585,340.3 | 1,135,701,442.27 | 845,084,320.3 | 556,922,772 |
| 二、营业总成本 | 249,380,131.57 | 1,023,246,062.16 | 752,127,483.02 | 489,596,811.21 |
| 营业成本 | 194,922,498.09 | 819,182,797.9 | 590,427,890.11 | 382,565,407.85 |
| 税金及附加 | 3,065,384.15 | 12,576,433.76 | 8,935,216.86 | 5,087,421.29 |
| 销售费用 | 9,236,680.59 | 55,985,805.5 | 41,717,887.17 | 26,072,672.86 |
| 管理费用 | 24,990,847.54 | 92,924,788.39 | 76,162,010.4 | 52,255,089.82 |
| 研发费用 | 11,658,672.54 | 45,600,760.16 | 38,044,278.04 | 25,119,400.3 |
| 财务费用 | 5,506,048.66 | -3,024,523.55 | -3,159,799.56 | -1,503,180.91 |
| 其中:利息费用 | 1,643,893.34 | 5,650,950.56 | 5,507,067.04 | 3,660,308.98 |
| 其中:利息收入 | 4,269,830.04 | 17,841,341.08 | 13,590,208.15 | 6,688,140.06 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 679,294.41 | 2,314,941.97 | -557,249.18 | -528,936.68 |
| 加:投资收益 | -160,595.94 | -12,473,617.44 | -8,057,665 | -8,402,556.05 |
| 资产处置收益 | -65,150.31 | -36,738.8 | 181,313.34 | 225,096.57 |
| 资产减值损失(新) | -2,924,842.33 | -37,367,364.97 | -4,941,180.92 | -2,464,096.17 |
| 信用减值损失(新) | -722,192.28 | -3,424,592.13 | -3,350,567.51 | -2,574,440.19 |
| 其他收益 | 1,005,724.04 | 3,763,816.96 | 3,110,658.77 | 2,506,650.88 |
| 四、营业利润 | 37,017,446.32 | 65,231,825.7 | 79,342,146.78 | 56,087,679.15 |
| 加:营业外收入 | 0.04 | 3,352.74 | 9,177.67 | 5,650.7 |
| 减:营业外支出 | 1,799.12 | 2,400,433.49 | 256,035.79 | 238,212.9 |
| 五、利润总额 | 37,015,647.24 | 62,834,744.95 | 79,095,288.66 | 55,855,116.95 |
| 减:所得税费用 | 5,068,573.34 | 11,455,190.18 | 7,204,990.44 | 5,532,784.33 |
| 六、净利润 | 31,947,073.9 | 51,379,554.77 | 71,890,298.22 | 50,322,332.62 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 31,947,073.9 | 51,379,554.77 | 71,890,298.22 | 50,322,332.62 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 31,992,144.45 | 51,507,174.7 | 71,964,592.87 | 50,349,314.66 |
| 少数股东损益 | -45,070.55 | -127,619.93 | -74,294.65 | -26,982.04 |
| 扣除非经常损益后的净利润 | 31,417,044.78 | 62,223,549.18 | 80,126,777.39 | 59,756,341.35 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.15 | 0.23 | 0.33 | 0.23 |
| (二)稀释每股收益 | 0.15 | 0.23 | 0.33 | 0.23 |
| 八、其他综合收益 | -3,600,274.63 | -9,653,798.4 | -5,079,463.63 | -1,836,428.21 |
| 归属于母公司股东的其他综合收益 | -3,600,274.63 | -9,653,798.4 | -5,079,463.63 | -1,836,428.21 |
| 九、综合收益总额 | 28,346,799.27 | 41,725,756.37 | 66,810,834.59 | 48,485,904.41 |
| 归属于母公司股东的综合收益总额 | 28,391,869.82 | 41,853,376.3 | 66,885,129.24 | 48,512,886.45 |
| 归属于少数股东的综合收益总额 | -45,070.55 | -127,619.93 | -74,294.65 | -26,982.04 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-30 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |